Successful Living Donor Liver Transplantation for Decompensated Chronic Liver Failure

PACE Hospitals

PACE Hospitals’ expert Liver Transplant team successfully performed a Living Donor Liver Transplantation (LDLT) on a 47-year-old male patient with decompensated chronic liver failure, ascites, hepatic encephalopathy, and hepatorenal syndrome. The aim of the procedure was to replace the diseased liver, restore liver function, manage associated complications, and prevent further life-threatening deterioration.


Chief Complaints

A 47-year-old male patient with a Body Mass Index (BMI) of 21 presented to the Liver Transplant Department at PACE Hospitals, Hitech City, Hyderabad, with abdominal distension due to ascites. He also had complications related to advanced liver disease, including hepatic encephalopathy and impaired kidney function associated with hepatorenal syndrome.

Past Medical History

The patient was a known case of chronic liver disease with recurrent ascites. His condition was complicated by hepatorenal syndrome and hepatic encephalopathy, indicating progression to decompensated liver failure. He was admitted for further evaluation and management due to worsening liver function and associated complications.

On Examination

On examination, the patient was conscious, coherent, and oriented. Abdominal distension was present due to fluid accumulation. He appeared clinically unwell, and a detailed systemic examination was carried out as part of the liver transplant evaluation.

Diagnosis

Following the clinical evaluation, the liver transplant team conducted a comprehensive assessment based on the patient’s history of chronic liver disease, abdominal distension due to ascites, hepatic encephalopathy, and impaired kidney function associated with hepatorenal syndrome.


A detailed medical history, physical examination, and required laboratory and imaging investigations were carried out to assess liver function, kidney function, fluid accumulation, coagulation status, and the overall severity of the disease. Based on the evaluation, the patient was diagnosed with decompensated chronic liver failure with ascites, hepatic encephalopathy, and hepatorenal syndrome.


The patient’s MELD-Na score was 24, indicating advanced liver disease and an increased risk of further complications.


Based on the confirmed diagnosis, he was advised to undergo Decompensated Chronic Liver Failure Treatment in Hyderabad, India, under the care of the liver transplant team.

Medical Decision-Making (MDM)

After detailed consultation with Dr. CH Madhusudhan (Senior Consultant Surgical Gastroenterologist and Liver Transplant Surgeon), Dr. Govind Verma (senior consultant interventional gastroenterologist and hepatologist), Dr. Suresh Kumar (Consultant Surgical Gastroenterologist), and the internal medicine team, the patient’s clinical condition and investigation findings were reviewed to determine the most appropriate treatment plan.


Considering the advanced stage of liver disease, recurrent ascites, hepatic encephalopathy, hepatorenal syndrome, and a MELD-Na score of 24, it was determined that Living Donor Liver Transplantation was identified as the most suitable definitive intervention.


The patient’s wife voluntarily came forward as the living liver donor. Blood group testing showed that both donor and recipient were B positive. After completing donor evaluation, recipient assessment, medical fitness checks, and necessary clearances, transplantation using a modified right lobe liver graft was planned.


The patient, donor, and family members were counselled regarding the severity of the disease, the transplant procedure, possible risks and complications, postoperative care, long-term medicines to prevent graft rejection, and the importance of regular follow-up.

Surgical Procedure

Following the decision, the patient was scheduled to undergo Living Donor Liver Transplantation (LDLT) in Hyderabad at PACE Hospitals under the expert supervision of the liver transplant team.


The following steps were carried out during the procedure:


  • Preoperative Preparation and Anaesthesia: After completing the required donor and recipient investigations, medical clearances, and informed consent, the patient was taken up for surgery under general anaesthesia with continuous monitoring.


  • Abdominal Exploration and Liver Mobilization: The abdominal cavity was accessed, and the diseased liver was carefully assessed. The liver was mobilized from the surrounding structures while controlling bleeding and protecting nearby organs.


  • Native Liver Removal: The major blood vessels and bile duct connected to the diseased liver were carefully identified and controlled. The native liver was then removed to prepare the recipient site for transplantation.


  • Modified Right Lobe Graft Implantation: A modified right lobe liver graft donated by the patient’s wife was placed in the recipient’s abdomen. The graft was positioned appropriately to restore liver function.


  • Vascular and Biliary Reconstruction: The graft blood vessels were connected to the recipient’s blood vessels to restore blood flow. The bile duct was also reconstructed to allow proper drainage of bile from the transplanted liver.


  • Graft Assessment and Closure: After confirming satisfactory blood flow to the graft and controlling bleeding, the surgical area was carefully checked. The abdomen was closed in layers, and the patient was shifted for close postoperative monitoring.

Postoperative Care

The postoperative period was uneventful, except for a temporary requirement for oxygen support, which was gradually weaned off. Increased abdominal drain output was managed conservatively with albumin support. Intravenous fluids, urine output, kidney function, graft function, and overall recovery were closely monitored. Medicines to prevent graft rejection and infection, provide gastric protection, control pain, nausea, and fever, and support nutrition were given as required. The doses of anti-rejection medicines were adjusted according to liver function test results.

Discharge Medications

Upon discharge, the patient was advised to take medicines to protect the transplanted liver and prevent rejection, prevent bacterial and fungal infections, provide gastric protection, manage pain, nausea, and fever, and support nutrition and recovery. He was instructed to take all medicines exactly as prescribed and not to alter transplant-related medicines without medical advice.

Advice on Discharge 

The patient was advised to maintain proper wound and drain care, follow the recommended diet, take medicines regularly, and protect himself from infections. He was also instructed to attend all scheduled follow-up visits so that liver function, kidney function, and medicine doses could be monitored.

Emergency Care

The patient was advised to contact the emergency ward at PACE Hospitals in case of any emergency or development of symptoms such as fever, abdominal pain, repeated vomiting, breathing difficulty, reduced urine output, worsening jaundice, confusion, bleeding, wound discharge, or any sudden deterioration in his condition.

Review and Follow-Up Notes

The patient was advised to return for a follow-up visit with the Surgical Gastroenterologist in Hyderabad at PACE Hospitals, to monitor transplanted liver and kidney function, assess recovery, adjust anti-rejection medicines, and identify any early signs of infection, rejection, or other complications.

Conclusion

This case highlights the successful management of decompensated chronic liver failure with ascites, hepatic encephalopathy, and hepatorenal syndrome through Living Donor Liver Transplantation. The patient recovered well after surgery and was discharged in stable condition with medications, counselling, and follow-up advice.

Comprehensive Care for Decompensated Liver Failure with Hepatorenal Syndrome

Decompensated liver failure can affect several organs, particularly the kidneys, and may lead to hepatorenal syndrome. Patients may also develop ascites, hepatic encephalopathy, fluid imbalance, and other serious complications that require timely evaluation by a Liver Transplant doctor/specialist. Management focuses on stabilising the patient, monitoring liver and kidney function, maintaining fluid balance, treating complications, and assessing suitability for liver transplantation when required. After transplantation, close monitoring of graft function, urine output, infection risk, fluid status, and response to medicines is essential for recovery.


Coordinated care involving hepatology, liver transplant surgery, critical care, anaesthesia, nursing, and transplant support teams plays an important role in improving outcomes in patients with advanced liver failure and hepatorenal syndrome.

Frequently Asked Questions (FAQs)


  • What is decompensated chronic liver failure?

    Decompensated chronic liver failure is an advanced stage of liver disease in which the liver can no longer perform its functions properly. Patients may develop complications such as jaundice, fluid accumulation in the abdomen, bleeding, confusion, and kidney problems. These complications require prompt evaluation by a liver specialist.

  • Why was abdominal drain output monitored after surgery?

    Abdominal drains help doctors monitor fluid collecting around the transplanted liver after surgery. The amount and appearance of the fluid may provide early signs of bleeding, bile leakage, infection, or continued ascitic fluid loss.

  • How does ascites develop in advanced liver disease?

    Ascites develops when scarring of the liver increases pressure in the portal blood vessels and affects the body’s fluid balance. Reduced liver function and changes in blood circulation cause salt and water to collect inside the abdomen. 

  • Why does hepatorenal syndrome need urgent treatment?

    Hepatorenal syndrome is a serious condition in which kidney function rapidly worsens because of advanced liver disease and changes in blood circulation. Without timely treatment, kidney function and the patient’s overall condition may deteriorate quickly. Urgent specialist care is needed to improve circulation, support kidney function, treat contributing factors, and assess the need for liver transplantation.

  • What symptoms suggest hepatic encephalopathy is worsening?

    Worsening hepatic encephalopathy may cause increasing confusion, unusual behaviour, poor concentration, memory problems, disturbed sleep, hand-flapping tremors, excessive drowsiness, or difficulty responding normally. Severe cases may cause loss of consciousness.

  • How is the severity of chronic liver failure assessed?

    Doctors assess liver failure using the patient’s symptoms, physical examination, blood tests, kidney function, blood-clotting ability, and imaging studies. Scoring systems such as MELD-Na may also be used to estimate disease severity and the urgency of liver transplantation. A higher MELD-Na score generally indicates more advanced disease and a greater risk of complications.

  • How much of the liver is removed from a living donor?

    The amount removed depends on the recipient’s size, the donor’s liver anatomy, and the amount of liver that must safely remain in the donor. Living liver donation may involve removing approximately 25%–60% of the donor’s liver. A larger right lobe is commonly considered for an adult recipient, but the final decision is made after detailed scans and donor safety assessment.

  • What are the possible risks of a modified right lobe liver graft?

    Possible risks include bleeding, infection, rejection, bile leakage or narrowing, blood clots in the graft vessels, and delayed or poor graft function. These complications do not occur in every patient, but close monitoring through blood tests, Doppler scans, drain assessment, and clinical examinations helps doctors detect and manage them early.

  • How does albumin support help in patients with increased fluid loss?

    Albumin is a blood protein that helps maintain fluid within the blood vessels. When a patient loses a significant amount of fluid through abdominal drains or ascites treatment, albumin may be given to support circulating blood volume and reduce the risk of low blood pressure or kidney dysfunction. It is administered according to the patient’s fluid balance and clinical condition.

  • How long does recovery usually take after living donor liver transplantation?

    Recovery varies depending on the patient’s health before surgery and whether complications develop. Many liver transplant recipients remain in the hospital for around 7–14 days, including initial monitoring in the ICU. Activities are gradually increased after discharge, and moderate exercise may be considered after about 8 weeks when recovery is satisfactory, although complete recovery can take several months.

Share on

Request an appointment

Fill in the appointment form or call us instantly to book a confirmed appointment with our super specialist at 04048486868

Appointment request - health articles

Recent Articles

World Brain Day 22 July 2026 – Importance, Theme & History | International Brain Day
By PACE Hospitals July 17, 2026
🧠 Happy World Brain Day 2026! Explore the 5 pillars of brain health, understand this year’s theme, “Access for All,” and take steps to protect your brain.
Case study of successful Transition from hemodialysis to peritoneal dialysis by PACE Hospitals
By PACE Hospitals July 17, 2026
Explore successful peritoneal dialysis catheter insertion for Stage V chronic kidney disease in a 68 Y.O. male by nephrology specialists at PACE Hospitals.
Successful Living Donor Liver Transplantation for Chronic Liver Failure at PACE Hospitals
By PACE Hospitals July 17, 2026
Discover successful living donor liver transplantation for decompensated liver cirrhosis with kidney disease in a 49 Y.O. male by liver transplant specialists at PACE Hospitals.
Case study of successful laparoscopic pancreaticojejunostomy (LPJ) and splenectomy on a 38-year-old
By PACE Hospitals July 16, 2026
Explore successful laparoscopic pancreaticojejunostomy with splenectomy for acute-on-chronic pancreatitis in a 38 Y.O. male by surgical gastroenterologists at PACE Hospitals.
Case study of Successful Living donor Liver transplant of infant at PACE Hospitals, Hyderabad, India
By PACE Hospitals July 16, 2026
Discover successful living donor liver transplantation for progressive liver dysfunction after Kasai surgery in a 9-month-old infant at PACE Hospitals.
Successful Living Donor Liver Transplant for Wilson’s Disease Treatment at PACE Hospitals
By PACE Hospitals July 15, 2026
Explore successful living donor liver transplantation for Wilson’s disease in a 24 Y.O. female by liver transplant specialists at PACE Hospitals.